Medicare Enrolled

Dr. Kompal Parmar, M.D.

Family Medicine · Lubbock, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
9812 SLIDE RD, Lubbock, TX 79424
8067258444
In practice since 2011 (14 years)
NPI: 1710270988 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Parmar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parmar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Parmar

Dr. Kompal Parmar is a family medicine in Lubbock, TX, with 14 years in practice. Based on federal Medicare data, Dr. Parmar performed 8,907 Medicare services across 4,543 unique beneficiaries.

Between the years covered by Open Payments, Dr. Parmar received a total of $10,224 from 45 pharmaceutical and/or device companies across 580 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Parmar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice▲ Top 2% volume in TX$ $10,224 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,907
Medicare services
Top 2% in TX for family medicine
4,543
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~636 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging (iodine-based)2,833$0$1
Blood draw (venipuncture)578$8$18
Office visit, established patient (30-39 min)548$78$172
Office visit, established patient (20-29 min)524$58$111
Complete blood count (CBC) with differential520$8$32
Comprehensive metabolic blood panel516$10$45
Thyroid stimulating hormone (TSH) test384$16$71
Free thyroxine (T4) test366$9$38
Lipid panel (cholesterol and triglycerides)307$13$93
Hemoglobin A1c test (diabetes monitoring)204$9$40
Annual wellness visit, follow-up191$124$341
Urinalysis with microscopic exam100$3$13
Ceftriaxone antibiotic injection100$0$30
Urine microalbumin test (kidney screening)99$6$25
Creatinine test (kidney function)92$5$21
Low dose ct scan of chest for lung cancer screening90$86$325
Drug injection, under skin or into muscle86$8$63
Steroid injection (triamcinolone)80$1$10
Chest X-ray, 2 views77$16$102
Flu vaccine administration76$5$5
Vitamin D level test75$29$124
Bone density scan (DEXA)73$28$305
Flu vaccine, quadrivalent62$69$70
CT scan of chest, without contrast53$64$336
X-ray of hand, 2 views51$17$57
Vitamin B-12 level test51$15$63
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use50$283$690
Pneumonia vaccine administration49$5$5
Uric acid level test48$4$19
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen44$50$160
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique41$34$100
Shoulder X-ray, 2+ views39$17$68
PSA test (prostate cancer screening)34$18$77
X-ray of knee, 1-2 views31$17$60
Electrocardiogram (EKG), 12-lead27$8$80
Natriuretic peptide (heart and blood vessel protein) level26$38$142
X-ray of foot, 2 views25$16$57
Ct scan of abdomen and pelvis without contrast20$74$374
Folic acid level test20$14$62
X-ray of upper spine, 2-3 views19$16$72
X-ray of lower and sacral spine, 2-3 views19$20$80
Kidney function blood test panel17$9$36
Amylase (enzyme) level17$6$27
Hip X-ray, 2-3 views16$23$122
Lipase (fat enzyme) level16$7$29
Iron level test15$6$27
Transferrin (iron binding protein) level15$12$54
Detection test by nucleic acid for multiple types influenza virus15$94$160
CT scan of head/brain, without contrast14$51$244
Ferritin level test (iron stores)14$13$57
C-reactive protein test (inflammation marker)14$5$21
Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage14$22$40
X-ray of pelvis, 1-2 views13$14$60
Inhalation treatment for airway obstruction or sputum production13$7$38
New patient office visit (30-44 min)13$66$202
Injection, methylprednisolone sodium succinate, up to 125 mg13$3$10
X-ray of lower and sacral spine, minimum of 4 views12$29$109
Foot X-ray, 3+ views12$17$62
Troponin (protein) analysis, quantitative12$12$41
Sed rate test (inflammation marker)12$3$11
Office visit, established patient (10-19 min)12$39$79
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,224
Total received (2018-2024)
Avg $1,461/year across 7 years
Top 5% in TX for family medicine
45
Companies
580
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,010 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$114 (1.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,695
2023
$1,786
2022
$1,420
2021
$1,724
2020
$1,193
2019
$1,166
2018
$1,240

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$1,524
ABBVIE INC.
$1,309
GlaxoSmithKline, LLC.
$985
AstraZeneca Pharmaceuticals LP
$863
Amgen Inc.
$714
Novo Nordisk Inc
$476
PFIZER INC.
$453
AbbVie Inc.
$441
Astellas Pharma US Inc
$371
Amarin Pharma Inc.
$342
Radius Health, Inc.
$341
Takeda Pharmaceuticals U.S.A., Inc.
$252
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$187
Allergan, Inc.
$182
Biohaven Pharmaceutical Holding Company Ltd.
$179
Allergan Inc.
$156
Ethicon US, LLC
$120
Ardelyx, Inc.
$111
TherapeuticsMD, Inc.
$107
COMSORT, Inc
$100
AbbVie, Inc.
$97
Merck Sharp & Dohme LLC
$95
Bayer HealthCare Pharmaceuticals Inc.
$93
Merck Sharp & Dohme Corporation
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$82
Bayer Healthcare Pharmaceuticals Inc.
$75
Exact Sciences Corporation
$68
Biohaven Pharmaceuticals, Inc.
$48
UPSHER-SMITH LABORATORIES LLC
$42
Dexcom, Inc.
$39
DEXCOM, INC.
$35
Nestle HealthCare Nutrition Inc.
$31
Teva Pharmaceuticals USA, Inc.
$30
Lexicon Pharmaceuticals, Inc.
$22
Eisai Inc.
$20
Abbott Laboratories
$18
Phathom Pharmaceuticals, Inc.
$17
Alvogen Inc
$17
Paratek Pharmaceuticals, Inc.
$17
SANOFI-AVENTIS U.S. LLC
$16
Melinta Therapeutics, Inc.
$13
Avion Pharmaceuticals
$12
Sanofi Pasteur Inc.
$11
MannKind Corporation
$11
Lupin Inc.
$11
Top 3 companies account for 37.3% of total payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · BASAGLAR · BELSOMRA · BIJUVA · BREO · BREZTRI · BYSTOLIC · Balcoltra · Baxdela · CHANTIX · COLOGUARD · COMIRNATY · CREON · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · EMGALITY · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · IBSRELA · JANUVIA · JARDIANCE · Kerendia · LINZESS · LO LOESTRIN FE · MENVEO · MOUNJARO · MYRBETRIQ · Myrbetriq · NURTEC ODT · NUZYRA · Otezla · Ozempic · PREMARIN · PREVNAR 13 · Prolia · QULIPTA · REYVOW · Repatha · Rybelsus · SHINGRIX · SIVEXTRO · STEGLATRO · SUPRAX · SYMBICORT · SYNJARDY XR · SYNTHROID · TERIPARATIDE · TOSYMRA · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Tymlos · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · XIFAXAN · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for family medicine in TX.

Equivalent to $115 per 100 Medicare services performed
Looking for a family medicine in Lubbock?
Compare family medicines in the Lubbock area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
111
Per 100K population
35.3
County median income
$63,367
Nearest hospital
EXCEPTIONAL COMMUNITY HOSPITAL LUBBOCK
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Parmar is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 5%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Parmar experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Parmar performed 2,833 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parmar receive payments from pharmaceutical companies?
Yes. Dr. Parmar received a total of $10,224 from 45 companies across 580 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parmar's costs compare to other family medicines in Lubbock?
Dr. Parmar's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parmar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →